Vimarsana
Biggest News Aggregation in the World

Page 42 - Randomized Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Clinical Today - Breaking & Trending Today

Spinal cord burst stimulation fails to improve back pain-related disability following lumbar spine surgery - Vimarsana News

Spinal cord burst stimulation fails to improve back pain-related disability following lumbar spine surgery

NORWAY: Researchers have found in a new study that Spinal cord burst stimulation fails to improve back pain-related disability following lumbar spine surgery. According to a study published in JAMA...

Vitamin D3 and Omega-3 supplementation fails to improve cardiac function: VITAL trial - Vimarsana News

Vitamin D3 and Omega-3 supplementation fails to improve cardiac function: VITAL trial

United states: A study published in the Journal of the American Heart Association, JAHA, has concluded that in adults aged ≥50 years, there is no significant effect of vitamin D3 and Omega-3 fatty...

Performance Lab Flex Review 2022 For Joint Health & Flexibility - Vimarsana News

Performance Lab Flex Review 2022 For Joint Health & Flexibility

Without healthy joints, movement is difficult, requiring supplements. This Performance Lab Flex 2023 Review explores its effectiveness.

Adherence to low carbohydrate diet reduces blood sugar and HbA1c in Prediabetics: JAMA - Vimarsana News

Adherence to low carbohydrate diet reduces blood sugar and HbA1c in Prediabetics: JAMA

Louisiana: Researchers at Tulane University have found in a randomized clinical trial that sticking to a low-carbohydrate diet helped people with prediabetes bring down their HbA1c in just a few...

Seres Therapeutics' ECOSPOR III Study Data on SER-109 Published in Journal of the American Medical Association - Vimarsana News

Seres Therapeutics' ECOSPOR III Study Data on SER-109 Published in Journal of the American Medical Association

– Summarized data from the study's secondary endpoints show investigational oral microbiome therapeutic rapidly and durably lowered risk of recurrent C. difficile infection – ... | October 19, 2022